Literature DB >> 6260984

Mutational changes in the vesicular stomatitis virus glycoprotein affect the requirement of carbohydrate in morphogenesis.

P A Chatis, T G Morrison.   

Abstract

The role of carbohydrate in the morphogenesis of vesicular stomatitis virus was studied, using the antibiotic tunicamycin to inhibit glycosylation. It has been reported previously (Gibson et al., J. Biol. Chem. 254:3600-3607, 1979) that the San Juan strain of vesicular stomatitis virus requires carbohydrate for efficient migration of the glycoprotein (G) to the cell surface and for virion formation, whereas the prototype or Orsay strain of vesicular stomatitis virus is less stringent in its carbohydrate requirement at 30 degrees C. However, there are many differences between the two strains. We found that mutational changes within the G protein of the same strain of virus (prototype or Orsay) alters the requirement for carbohydrate at 30 degrees C. Group V or G protein mutants tsO45 and tsO44, like their prototype parent, did not require carbohydrate for efficient morphogenesis. In contrast, the G protein of another group V mutant, tsO110, was totally dependent upon carbohydrate addition for migration to the cell surface. Furthermore, no tsO110 particles were released in the absence of glycosylation. The wild-type prototype strain did require carbohydrate at 39.5 degrees C for insertion of the G protein into the plasma membrane and virion formation. However, a pseudorevertant of tsO44 (tsO44R), unlike the prototype parent, no longer exhibited this temperature-sensitive requirement for carbohydrate. At 39.5 degrees C in the presence of tunicamycin, tsO44R-infected cells released normal yields of particles and the unglycosylated G reached the cell surface very efficiently. In contrast to tsO110, which absolutely requires carbohydrate, mutational change in the tsO44R G protein has eliminated the requirement for carbohydrate. Thus, simple mutational changes, as opposed to many changes in the molecule, are sufficient to alter the carbohydrate requirement.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260984      PMCID: PMC171008     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V.

Authors:  F Lafay
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

2.  [Genetic study of vesicular stomatitis virus: classification of spontaneous thermosensitive mutants into complementation groups].

Authors:  A Flamand
Journal:  J Gen Virol       Date:  1970-09       Impact factor: 3.891

3.  [Thermosensitive vesicular stomatitis virus (SVS) mutants. Maturation mutants].

Authors:  F Lafay; A Berkaloff
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-09-15

4.  The cell-free synthesis and assembly of viral specific polypeptides into TMV particles.

Authors:  B E Roberts; B M Paterson; R Sperling
Journal:  Virology       Date:  1974-05       Impact factor: 3.616

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  On the biological role of glycoproteins.

Authors:  E H Eylar
Journal:  J Theor Biol       Date:  1966-01       Impact factor: 2.691

7.  Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

8.  [Study of thermosensitive mutants of vesicular stomatitis virus (VSV). Classification of some mutants on a functional basis].

Authors:  F Lafay
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-05-12

9.  Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

Authors:  A Takatsuki; K Arima; G Tamura
Journal:  J Antibiot (Tokyo)       Date:  1971-04       Impact factor: 2.649

10.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.

Authors:  R Leavitt; S Schlesinger; S Kornfeld
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  10 in total

1.  Virus-lymphocyte interactions: inductive signals necessary to render B lymphocytes susceptible to vesicular stomatitis virus infection.

Authors:  M R Schmidt; R T Woodland
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

Review 2.  The genetics of vesiculoviruses.

Authors:  C R Pringle
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Biosynthesis of measles virus hemagglutinin in persistently infected cells.

Authors:  W J Bellini; G D Silver; D E McFarlin
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

4.  Maturation of the envelope glycoproteins of Newcastle disease virus on cellular membranes.

Authors:  J C Schwalbe; L E Hightower
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

5.  Characterization of the soluble glycoprotein released from vesicular stomatitis virus-infected cells.

Authors:  P A Chatis; T G Morrison
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

7.  Fatty acid modification of Newcastle disease virus glycoproteins.

Authors:  P A Chatis; T G Morrison
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

Review 8.  Viral glycoprotein metabolism as a target for antiviral substances.

Authors:  H D Klenk; R T Schwarz
Journal:  Antiviral Res       Date:  1982-09       Impact factor: 5.970

9.  Addicted to sugar: roles of glycans in the order Mononegavirales.

Authors:  Victoria Ortega; Jacquelyn A Stone; Erik M Contreras; Ronald M Iorio; Hector C Aguilar
Journal:  Glycobiology       Date:  2019-01-01       Impact factor: 4.313

Review 10.  Domains of virus glycoproteins.

Authors:  M J Schlesinger; S Schlesinger
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.